AGP Executive Report
Last update: 19 minutes agoMental Health: A new analysis involving Radboud University researcher Eric Ruhé found escitalopram may help prevent depression relapse better than fluoxetine. The differences were modest, and researchers cautioned patients not to change a treatment that is working. Embryo Research: The Dutch Senate narrowly approved a law allowing embryos to be created for research, which supporters say could improve IVF and inherited-disease detection. Alzheimer’s Research: A study led by Vrije Universiteit Amsterdam analyzed 2.8 million people and identified 127 genetic regions linked to Alzheimer’s risk, including 48 not previously mapped. Infectious Disease: West Nile virus has killed 12 people in the Netherlands this year, after only eight cases had been recorded previously, according to a recent report. Drug Access: Dutch antitrust regulators are probing Biogen over a test for its multiple sclerosis drug, raising questions about competition and patient access.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.